TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31393072

Group type: EXPERIMENTAL
Intervention: NCPAP
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: NIV-NAVA
Number of subjects: 123
Study: 27869481

Group type: EXPERIMENTAL
Intervention: Papillary approach (Group 1)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Infundibular approach (Group 2)
Number of subjects: 55
Study: 25634934

Group type: EXPERIMENTAL
Intervention: Presentation of information about nicotine and toxicity in smokeless tobacco products
Number of subjects: 0

Group type: COMPARATOR
Intervention: Presentation of toxicity information alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Presentation of information about SLT and cigarette products
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall presentation of tobacco constituent information
Number of subjects: 0
Study: 23866179

Group type: EXPERIMENTAL
Intervention: Ticagrelor (180 mg)
Number of subjects: 2616

Group type: COMPARATOR
Intervention: Clopidogrel (300 mg, 75 mg for pre-treated patients)
Number of subjects: 2616
Study: 21428727

Group type: EXPERIMENTAL
Intervention: Sitagliptin (100 or 50 mg, depending on renal function)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 206
Study: 19216813

Group type: EXPERIMENTAL
Intervention: Large food portions
Number of subjects: 43

Group type: COMPARATOR
Intervention: Standard food portions
Number of subjects: 43
Study: 17910226

Group type: EXPERIMENTAL
Intervention: Enforce (E)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: RelyX ARC (RX)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Fill Magic Dual Cement (FM)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intact teeth (Control)
Number of subjects: 40
Study: 15492353

Group type: EXPERIMENTAL
Intervention: Risperidone (0.01-0.06 mg/kg/day, mean dosage: 0.04 mg/kg/day)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 79
Study: 12088139

Group type: EXPERIMENTAL
Intervention: Comprehensive intervention including parent training, social behavior interventions, and supplementary reading instruction over a 2-year period
Number of subjects: 284

Group type: COMPARATOR
Intervention: No-intervention control condition
Number of subjects: 284
Study: 10094445

Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.15 mg/kg per 6 h for 4 days)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control (antibiotics alone)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control
Number of subjects: 52
Study: 8625186

Group type: COMPARATOR
Intervention: IL-2 alone
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: IL-2 plus LAK
Number of subjects: 71
Study: 2187651

Group type: EXPERIMENTAL
Intervention: ioversol-240
Number of subjects: 50

Group type: COMPARATOR
Intervention: iohexol-240 (Omnipaque-240)
Number of subjects: 50
Study: 6996137

Group type: EXPERIMENTAL
Intervention: Tienilic acid
Number of subjects: 23

Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 23
Study: 6548926

Group type: EXPERIMENTAL
Intervention: Almax (6-8 g/d)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Almax (4 g/d) with antisecretory drugs (cimetidine or ranitidine)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Almax (lower doses)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Almax (all groups)
Number of subjects: 169
Study: 31679170

Group type: EXPERIMENTAL
Intervention: Presession Attention (PA)
Number of subjects: 6

Group type: COMPARATOR
Intervention: No Presession Attention (NPA)
Number of subjects: 6
Study: 30005707

Group type: EXPERIMENTAL
Intervention: Active acupuncture group receiving standardized 30-min real acupuncture treatment for a total of 16 sessions on top of standard routine care.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sham acupuncture group receiving sham acupuncture in addition to standard routine care.
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Active acupuncture group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sham acupuncture group
Number of subjects: 100
Study: 27374465

Group type: EXPERIMENTAL
Intervention: Rituximab maintenance therapy (375 mg/m² every 3 months for 2 years)
Number of subjects: 263

Group type: COMPARATOR
Intervention: Observation alone
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Rituximab maintenance therapy
Number of subjects: 263
Study: 23708056

Group type: EXPERIMENTAL
Intervention: L-arginine (9 g daily for 6 months)
Number of subjects: 88
Study: 22748516

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 184

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 184
Study: 20493971

Group type: EXPERIMENTAL
Intervention: Earlobe blood gases
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Earlobe pulse oximetry O(2) saturation (Sp(O2))
Number of subjects: 10

Group type: COMPARATOR
Intervention: Arterial blood gases
Number of subjects: 10
Study: 18371137

Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FeCarb) - maximum 1,000 mg iron per infusion at 1-week intervals until total iron deficit reached
Number of subjects: 200

Group type: COMPARATOR
Intervention: Oral ferrous sulfate (FeSulf) - 100 mg b.i.d. for 12 weeks
Number of subjects: 200
Study: 15855366

Group type: EXPERIMENTAL
Intervention: Posterior-cruciate-ligament-substituting total knee arthroplasty
Number of subjects: 44

Group type: COMPARATOR
Intervention: Posterior-cruciate-ligament-retaining total knee arthroplasty
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both designs
Number of subjects: 44
Study: 12621634

Group type: EXPERIMENTAL
Intervention: Unified Dystonia Rating Scale (UDRS)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Fahn‐Marsden Scale (F‐M)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Global Dystonia Rating Scale (GDS)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Comparison among scales (UDRS, F‐M, GDS)
Number of subjects: 100
Study: 10584678

Group type: EXPERIMENTAL
Intervention: Transdermal patch containing 35 mg nicotine
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 8631044

Group type: EXPERIMENTAL
Intervention: Candoxatril (8 patients)
Number of subjects: 12
Study: 1826594

Group type: EXPERIMENTAL
Intervention: Teicoplanin at 6 mg/kg every 12 h for three doses, then 6 mg/kg every 24 h
Number of subjects: 54

Group type: COMPARATOR
Intervention: Vancomycin at 15 mg/kg every 12 h
Number of subjects: 54
Study: 6961760

Group type: EXPERIMENTAL
Intervention: Labetalol (667 mg daily)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Propranolol (129 mg daily)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Labetalol (400 mg single oral dose)
Number of subjects: 18
Study: 30895881

Group type: EXPERIMENTAL
Intervention: Culturally tailored family-based self-management education and social support intervention (group education, home visits, telephone calls)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Wait list control group
Number of subjects: 157
Study: 28687934

Group type: EXPERIMENTAL
Intervention: KGB and AG (6 g of fibre from KGB and 3 g of AG)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: KGB and AG
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control (wheat bran-based, fibre-matched)
Number of subjects: 39
Study: 26990198

Group type: EXPERIMENTAL
Intervention: Enhanced sonification
Number of subjects: 76

Group type: COMPARATOR
Intervention: Conventional sonification
Number of subjects: 76
Study: 25129881

Group type: EXPERIMENTAL
Intervention: SRP + H (Homeopathy)
Number of subjects: 50

Group type: COMPARATOR
Intervention: SRP (Control Group)
Number of subjects: 50
Study: 22232563

Group type: EXPERIMENTAL
Intervention: Intravitreal injection of 1.25 mg bevacizumab
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 24
Study: 19605879

Group type: EXPERIMENTAL
Intervention: Motivational interviewing plus oral health education
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oral health education alone
Number of subjects: 60
Study: 17238881

Group type: EXPERIMENTAL
Intervention: Cisatracurium 0.15 mg x kg(‐1)
Number of subjects: 181
Study: 14618287

Group type: EXPERIMENTAL
Intervention: NMES (electromyographically triggered neuromuscular electrical stimulation)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: NMES
Number of subjects: 16
Study: 11240084

Group type: EXPERIMENTAL
Intervention: Oral transmucosal fentanyl citrate (OTFC)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Morphine sulfate immediate release (MSIR)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: OTFC
Number of subjects: 134
Study: 9712233

Group type: EXPERIMENTAL
Intervention: H. pylori-positive patients
Number of subjects: 80

Group type: COMPARATOR
Intervention: H. pylori-negative patients
Number of subjects: 80
Study: 7521041

Group type: EXPERIMENTAL
Intervention: DDDR pacing
Number of subjects: 0

Group type: COMPARATOR
Intervention: VVIR pacing
Number of subjects: 0
Study: 3044869

Group type: EXPERIMENTAL
Intervention: Ibuprofen 1600 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bendrofluazide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 0
Study: 31181244

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS with rTMS (tDCS-rTMS)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS (sham rTMS)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: rTMS (sham tDCS)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Sham control (no tDCS or rTMS)
Number of subjects: 11
Study: 28232973

Group type: EXPERIMENTAL
Intervention: Standard oral health intervention (spoken)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Written intervention
Number of subjects: 175

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 175
Study: 26390092

Group type: COMPARATOR
Intervention: rAAV9-DES-hGAA injected intramuscularly into the tibialis anterior muscle
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control injection of excipient dosing in the contralateral leg
Number of subjects: 6
Study: 23499204

Group type: EXPERIMENTAL
Intervention: Penicillin G sodium and gentamicin
Number of subjects: 200

Group type: COMPARATOR
Intervention: Clindamycin and amikacin
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 200
Study: 21135704

Group type: EXPERIMENTAL
Intervention: Probiotics (4 sachets of 2.5 billion bacteria per sachet for 7 days)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (4 sachets for 7 days)
Number of subjects: 50
Study: 19353264

Group type: EXPERIMENTAL
Intervention: Comprehensive Mixed‐Methods Participatory Evaluation (CMMPE) model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multilevel intervention
Number of subjects: 0
Study: 17088514

Group type: EXPERIMENTAL
Intervention: Duct tape
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study: 14681343

Group type: EXPERIMENTAL
Intervention: Nanocrystal budesonide 0.5 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Nanocrystal budesonide 1.0 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Pulmicort Respules 0.5 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 11265932

Group type: EXPERIMENTAL
Intervention: High‐Dk soft contact lenses
Number of subjects: 32

Group type: COMPARATOR
Intervention: Non-contact lens wearers
Number of subjects: 32
Study: 9313712

Group type: EXPERIMENTAL
Intervention: FOB testing and flexible sigmoidoscopy (FOS)
Number of subjects: 6371

Group type: COMPARATOR
Intervention: FOB testing alone
Number of subjects: 6371
Study: 8395476

Group type: EXPERIMENTAL
Intervention: High energy lunch (985 kcal)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Low energy lunch (527 kcal)
Number of subjects: 12

Group type: COMPARATOR
Intervention: High CHO dinner meal
Number of subjects: 12

Group type: COMPARATOR
Intervention: High fat dinner meal
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High energy lunch (985 kcal) with high fat dinner
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Low energy lunch (527 kcal) with high CHO dinner
Number of subjects: 12
Study: 3513080

Group type: EXPERIMENTAL
Intervention: Cimetidine/pyrilamine eyedrops (combination treatment)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Cimetidine eyedrops (alone)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Pyrilamine eyedrops (alone)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 18
Study: 29848153

Group type: EXPERIMENTAL
Intervention: Adalimumab (ADA)
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Etanercept (ETA)
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Ustekinumab (UST)
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: All biologics
Number of subjects: 269
Study: 30241509

Group type: EXPERIMENTAL
Intervention: Anterior minimally-invasive (AMIS) approach
Number of subjects: 190

Group type: COMPARATOR
Intervention: Lateral Hardinge (LAT) approach
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: AMIS group
Number of subjects: 190
Study: 25647283

Group type: EXPERIMENTAL
Intervention: Nondipper Hypertension (NDHT)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Dipper Hypertension (DHT)
Number of subjects: 77
Study: 25028536

Group type: EXPERIMENTAL
Intervention: Nanocrystal formulation of megestrol acetate (625 mg/5 mL) in fasting state
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Nanocrystal formulation of megestrol acetate (625 mg/5 mL) in fed state
Number of subjects: 93

Group type: COMPARATOR
Intervention: Megace OS (800 mg/20 mL) in fasting state
Number of subjects: 93

Group type: COMPARATOR
Intervention: Megace OS (800 mg/20 mL) in fed state
Number of subjects: 93
Study: 22930542

Group type: EXPERIMENTAL
Intervention: Intervention care (multidisciplinary intervention including screening questionnaire, education, pain medication management, physiotherapy-guided exercise, communication with primary care physician)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Intervention care
Number of subjects: 139

Group type: COMPARATOR
Intervention: Usual care (educational pamphlet)
Number of subjects: 139
Study: 19208609

Group type: EXPERIMENTAL
Intervention: Online module
Number of subjects: 99

Group type: COMPARATOR
Intervention: Textbook group
Number of subjects: 99

Group type: COMPARATOR
Intervention: Tutor-led group
Number of subjects: 99
Study: 19088619

Group type: EXPERIMENTAL
Intervention: Simulation-based training
Number of subjects: 57

Group type: COMPARATOR
Intervention: Conventional training
Number of subjects: 57
Study: 15375809

Group type: EXPERIMENTAL
Intervention: Heat wrap therapy
Number of subjects: 93

Group type: COMPARATOR
Intervention: Oral placebo
Number of subjects: 93
Study: 11277448

Group type: EXPERIMENTAL
Intervention: Peripheral informative cueing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Central informative cueing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Peripheral uninformative cueing
Number of subjects: 0
Study: 7978433

Group type: EXPERIMENTAL
Intervention: 12 mg of lyophilized tetracaine with 0.2 mg epinephrine in 2.5 mL 10% dextrose, Group 0: immediately turned supine after spinal injection
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 12 mg of lyophilized tetracaine with 0.2 mg epinephrine in 2.5 mL 10% dextrose, Group 6: 6 min in lateral decubitus then supine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 12 mg of lyophilized tetracaine with 0.2 mg epinephrine in 2.5 mL 10% dextrose, Group 12: 12 min in lateral decubitus then supine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 12 mg of lyophilized tetracaine with 0.2 mg epinephrine in 2.5 mL 10% dextrose, Group 18: 18 min in lateral decubitus then supine
Number of subjects: 60
Study: 2568061

Group type: EXPERIMENTAL
Intervention: Tap water iontophoresis
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Maintenance treatment every second week
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 31155871

Group type: EXPERIMENTAL
Intervention: Fire-needling plus stuck-needle-stretching
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional acupuncture
Number of subjects: 60
Study: 29034648

Group type: EXPERIMENTAL
Intervention: Interactive multimedia CD
Number of subjects: 120

Group type: COMPARATOR
Intervention: Educational booklet
Number of subjects: 120
Study: 26539769

Group type: EXPERIMENTAL
Intervention: Enhanced dissemination strategy
Number of subjects: 2940

Group type: COMPARATOR
Intervention: Basic dissemination strategy
Number of subjects: 2940

Group type: EXPERIMENTAL
Intervention: Enhanced dissemination strategy with nine or more Go Sun Smart materials
Number of subjects: 2940

Group type: COMPARATOR
Intervention: Basic dissemination strategy with fewer than nine Go Sun Smart materials
Number of subjects: 2940
Study: 23443764

Group type: EXPERIMENTAL
Intervention: Colloid preload with gelofusine at 10 ml·kg(‐1)·h(‐1)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Colloid preload with gelofusine at 5 ml·kg(‐1)·h(‐1)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Colloid preload with gelofusine at 15 ml·kg(‐1)·h(‐1)
Number of subjects: 45
Study: 21398038

Group type: EXPERIMENTAL
Intervention: Pregabalin (75 mg twice daily to a maximum of 300 mg twice daily for 28 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20193529

Group type: EXPERIMENTAL
Intervention: batroxobin
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Low Molecular Weight Heparin (LMWH)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: batroxobin and LMWH
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: urokinase and LMWH
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: micro pump administration of batroxobin
Number of subjects: 127
Study: 16960923

Group type: EXPERIMENTAL
Intervention: infliximab 5 mg/kg
Number of subjects: 200

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 200
Study: 12742333

Group type: EXPERIMENTAL
Intervention: Uterine artery Doppler examination and 100 mg aspirin daily from Doppler examination through 36 weeks
Number of subjects: 1853

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1853

Group type: EXPERIMENTAL
Intervention: Abnormal Doppler findings
Number of subjects: 1853
Study: 10683348

Group type: EXPERIMENTAL
Intervention: Eptifibatide
Number of subjects: 9641

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9641

Group type: COMPARATOR
Intervention: PCI
Number of subjects: 9641
Study: 9146853

Group type: EXPERIMENTAL
Intervention: Adrenaline infusion (20-160 ng kg-1 min-1)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Adrenaline infusion with ganglionic blockade (trimetaphan)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Plasma adrenaline levels
Number of subjects: 32
Study: 7639380

Group type: EXPERIMENTAL
Intervention: CPAP at 2 cm H2O (Group I)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: CPAP at 5 cm H2O (Group II)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Two-lung ventilation (control)
Number of subjects: 20
Study: 3218950

Group type: EXPERIMENTAL
Intervention: Metoclopramide (MTC) 10 mg IV
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Metopimazine (MTP) 10 mg IV
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (7 subjects)
Number of subjects: 14
Study: 31778823

Group type: EXPERIMENTAL
Intervention: GB001 5 mg
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: GB001 20 mg
Number of subjects: 158

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158
Study: 29126161

Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 6864

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6864

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 6864
Study: 26630400

Group type: EXPERIMENTAL
Intervention: IVR alone
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: PRP + IVR combined treatment
Number of subjects: 32

Group type: COMPARATOR
Intervention: PRP
Number of subjects: 32
Study: 26149717

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg twice daily
Number of subjects: 1861

Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg twice daily
Number of subjects: 1861

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1861
Study: 23388385

Group type: EXPERIMENTAL
Intervention: Community health worker (CHW) referral system
Number of subjects: 2423

Group type: EXPERIMENTAL
Intervention: CHW referral system
Number of subjects: 2423
Study: 22088040

Group type: EXPERIMENTAL
Intervention: Discrimination of sounds obeying the correlation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Discrimination of sounds violating the correlation
Number of subjects: 0
Study: 18782641

Group type: EXPERIMENTAL
Intervention: Exenatide once weekly (2 mg)
Number of subjects: 295

Group type: COMPARATOR
Intervention: Exenatide twice daily (10 µg)
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Exenatide once weekly
Number of subjects: 295

Group type: COMPARATOR
Intervention: Exenatide twice daily
Number of subjects: 295
Study: 16289254

Group type: EXPERIMENTAL
Intervention: Basic Italian Cognitive Questionnaire (BICQ)
Number of subjects: 963
Study: 14738210

Group type: EXPERIMENTAL
Intervention: Concentrated ambient particles (CAPs) exposure (200 microg/m3) for 2 hours
Number of subjects: 24

Group type: COMPARATOR
Intervention: Filtered air exposure
Number of subjects: 24
Study: 11776072

Group type: COMPARATOR
Intervention: Botox
Number of subjects: 785

Group type: EXPERIMENTAL
Intervention: CBTX‐A
Number of subjects: 785
Study: 9196108

Group type: EXPERIMENTAL
Intervention: Proportional assist ventilation (flow assist = 2 cm H2O/L/s plus volume assist = 4 cm H2O/L)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Proportional assist ventilation
Number of subjects: 13
Study: 8485793

Group type: EXPERIMENTAL
Intervention: Nifedipine 10 mg sublingually 20 min before induction of anaesthesia
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo sublingually 20 min before induction of anaesthesia
Number of subjects: 30
Study: 3688160

Group type: EXPERIMENTAL
Intervention: Moderate scarcity (two essential tools per three subjects)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: High scarcity (one essential tool per three subjects)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: No scarcity (three essential tools per three subjects)
Number of subjects: 36